Literature DB >> 5187926

Comparative inhibition of methicillin-resistant strains of Staphylococcus aureus by lysostaphin and other antibiotics.

W A Zygmunt, E F Harrison, H P Browder, P A Tavormina.   

Abstract

Sixteen methicillin-resistant strains of Staphylococcus aureus obtained from Europe were found to be sensitive to the lytic activity of lysotaphin. With only minor exceptions, the strains were found to be sensitive to novobiocin, erythromycin, fusidic acid, and lincomycin, and slightly less sensitive to vancomycin and chloramphenicol. All strains were resistant to tetracycline, penicillinase-sensitive penicillins (benzylpenicillin, ampicillin, and propicillin), penicillinase-resistant penicillins (methicillin, nafcillin, ancillin, oxacillin, cloxacillin, and dicloxacillin), and two cephalosporin antibiotics (cephalothin and cephaloridine).

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5187926      PMCID: PMC547615          DOI: 10.1128/am.16.8.1174-1178.1968

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  12 in total

1.  IN VITRO ACTIVITY OF PENICILLINS AGAINST STAPHYLOCOCCUS ALBUS.

Authors:  J O KJELLANDER; J O KLEIN; M FINLAND
Journal:  Proc Soc Exp Biol Med       Date:  1963 Aug-Sep

2.  CHARACTERISTICS OF METHICILLIN-RESISTANT STAPHYLOCOCCI.

Authors:  R SUTHERLAND; G N ROLINSON
Journal:  J Bacteriol       Date:  1964-04       Impact factor: 3.490

3.  RESISTANCE TO METHICILLIN, ISOXAZOLYL PENICILLINS, AND CEPHALOTHIN IN STAPHYLOCOCCUS AUREUS.

Authors:  K R ERIKSEN; I ERICHSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1964

4.  Amidopyrine and agranulocytosis.

Authors:  R G SIMPSON
Journal:  Br Med J       Date:  1963-03-30

5.  Evolutio of natural resistance to the newer penicillins.

Authors:  G T STEWART; R J HOLT
Journal:  Br Med J       Date:  1963-02-02

6.  Iodometric assay of penicillinase.

Authors:  C J PERRET
Journal:  Nature       Date:  1954-11-27       Impact factor: 49.962

7.  Penicillinase production and intrinsic resistance to penicillins in Staphylococcus aures.

Authors:  K G Dyke; M P Jevons; M T Parker
Journal:  Lancet       Date:  1966-04-16       Impact factor: 79.321

8.  Growth inhibition of unusual strains of Staphylococcus aureus by lysostaphin and other antistaphylococcal antibiotics.

Authors:  W A Zygmunt; H P Browder; P A Tavormina
Journal:  Can J Microbiol       Date:  1966-04       Impact factor: 2.419

9.  Inactivation of cephalothin and cephaloridine by Staphylococcus aureus.

Authors:  E J Benner; J V Bennett; J L Brodie; W M Kirby
Journal:  J Bacteriol       Date:  1965-12       Impact factor: 3.490

View more
  4 in total

1.  Efficacy and safety of topical lysostaphin treatment of persistent nasal carriage of Staphylococcus aureus.

Authors:  K E Quickel; R Selden; J R Caldwell; N F Nora; W Schaffner
Journal:  Appl Microbiol       Date:  1971-09

2.  Nuclease production and lysostaphin susceptibility of Staphylococcus aureus and other catalase-positive cocci.

Authors:  R V Lachica; P D Hoeprich; C Genigeorgis
Journal:  Appl Microbiol       Date:  1971-05

Review 3.  Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications.

Authors:  Maria do Carmo de Freire Bastos; Bruna Gonçalves Coutinho; Marcus Lívio Varella Coelho
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-19

Review 4.  Staphylococcal-Produced Bacteriocins and Antimicrobial Peptides: Their Potential as Alternative Treatments for Staphylococcus aureus Infections.

Authors:  Logan L Newstead; Katarina Varjonen; Tim Nuttall; Gavin K Paterson
Journal:  Antibiotics (Basel)       Date:  2020-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.